Testing AMH blood levels for PCOS and POI patients
Part of Cancer, Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at how a blood test called AMH (anti-Müllerian hormone) is used in people being seen for PCOS or POI (early ovarian failure). The goal is to understand whether AMH measurements are useful for care in clinics and fertility treatment settings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are being seen at a clinic for PCOS or POI at Prince of Wales Hospital
- OR you are receiving fertility treatment at the ART unit at The Chinese University of Hong Kong
- You are between 10 and 44 years old
- You do not have any current or past conditions that affect hormone signals or how hormones are processed in the body
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how certain blood markers relate to ovarian function in women with normal ovaries, diminished ovarian reserve (DOR), or primary ovarian insufficiency (POI). It may help doctors better understand these conditions.
This trial compares two hormone treatment protocols used during IVF to see which one leads to more genetically normal embryos in women with polycystic ovary syndrome (PCOS). It may help women with PCOS have better chances of a successful pregnancy.
This study helps doctors better understand polycystic ovary syndrome (PCOS)—a hormonal condition affecting ovulation—and how it relates to blood clotting problems. Researchers will collect blood samples and health information to create a risk assessment tool.
This study measures a hormone called AMH in girls before and after puberty. It’s done while participants have a routine outpatient surgery, to better understand what AMH levels look like in healthy children.
This study looks at whether a hormone level measured inside the fluid around eggs (follicular fluid) can predict whether embryos have the correct number of chromosomes. It may help clinics choose which embryos are more likely to be healthy.
This study compares two ways of retrieving eggs for fertility treatment in women with PCOS. One method is called IVM (maturation of eggs in the lab) and the other is conventional ovarian stimulation (taking hormones to mature eggs in the body). The goal is to see how each affects a woman's physical and mental well-being during the treatment process.
Hear when a new Premature Ovarian Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.